Tag results:
glioblastoma
Neural Cell News
Synergistic Immunotherapy of Glioblastoma by Dual Targeting of IL-6 and CD40
[Nature Communications] Researchers identified a Stat3/HIF-1α-mediated axis, through which IL-6 executed an anti-tumor role to induce CD40 expression in Mϕs.
Cancer Stem Cell News
Effects of the DRD2/3 Antagonist ONC201 and Radiation in Glioblastoma
[Radiotherapy and Oncology] Investigators suggested that combined treatment with the DRD2/3 antagonist ONC201 and radiation improves the efficacy of radiation against glioblastoma (GBM) in vitro and in vivo through suppression of glioma-initiating cells without increasing toxicity in mouse models of GBM.
Human Immunology News
Interactions between Cancer Cells and Immune Cells Drive Transitions to Mesenchymal-Like States in Glioblastoma
[Cancer Cell] Scientists dissected glioblastoma-to-microenvironment interactions by single-cell RNA sequencing analysis of human tumors and model systems, combined with functional experiments.
Cancer Stem Cell News
Altered Lipid Metabolism Marks Glioblastoma Stem and Non-Stem Cells in Separate Tumor Niches
[Acta Neuropathologica Communications] Investigators interrogated gene expression in separate microenvironments of glioblastoma organoid models that mimicked the transition between nutrient-rich and nutrient-poor pseudopalisading/perinecrotic tumor zones using spatial-capture RNA-sequencing.
Cell Therapy News
An Oncolytic Virus Expressing IL-15/IL-15Rα Combined with off-the-Shelf EGFR-CAR NK Cells Targets Glioblastoma
[Cancer Research] Scientists generated a herpes simplex 1-based oncolytic viruses expressing human IL-15/IL-15Rα sushi domain fusion protein, as well as off-the-shelf EGFR-CAR NK cells, and studied their monotherapy and combination efficacy in vitro and in multiple glioblastoma mouse models.
Umbilical & Placental Cell News
Interleukin-1β-Induced Matrix Metalloproteinase-3 via ERK1/2 Pathway to Promote Mesenchymal Stem Cell Migration
[PLOS ONE] Scientists proposed that IL-1β influences human umbilical cord Wharton's jelly derived mesenchymal stem cells migration involving matrix metalloproteinase-3.